• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Correction to 'Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical setting'.对“沙库巴曲缬沙坦在真实临床环境中治疗射血分数降低的心力衰竭的早期经验”的勘误
ESC Heart Fail. 2025 Apr;12(2):1525. doi: 10.1002/ehf2.15211. Epub 2025 Jan 17.
2
Initial Real-World Practical Experience of Sacubitril/Valsartan Treatment in Japanese Patients With Chronic Heart Failure.沙库巴曲缬沙坦治疗日本慢性心力衰竭患者的初步真实世界实践经验
Circ Rep. 2021 Sep 4;3(10):589-593. doi: 10.1253/circrep.CR-21-0068. eCollection 2021 Oct 8.
3
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction.评估沙库巴曲缬沙坦钠作为射血分数降低和射血分数保留的心力衰竭的治疗选择。
Expert Opin Pharmacother. 2022 Feb;23(3):303-320. doi: 10.1080/14656566.2022.2027909. Epub 2022 Jan 20.
4
Sacubitril/valsartan use in a real-world population of patients with heart failure and reduced ejection fraction.沙库巴曲缬沙坦在射血分数降低的心力衰竭真实世界人群中的应用。
J Cardiovasc Med (Hagerstown). 2020 Nov;21(11):882-888. doi: 10.2459/JCM.0000000000001018.
5
Our Experience With Sacubitril/Valsartan in Chronic Heart Failure Management - HFrEF in the Ambulatory Setting.我们在慢性心力衰竭管理中使用沙库巴曲缬沙坦的经验——门诊射血分数降低型心力衰竭。
Med Arch. 2022 Apr;76(2):101-107. doi: 10.5455/medarh.2022.76.101-107.
6
Sacubitril/Valsartan in the Treatment of Heart Failure With Reduced Ejection Fraction Focusing on the Impact on the Quality of Life: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.沙库巴曲缬沙坦治疗射血分数降低的心力衰竭：聚焦对生活质量的影响——一项随机临床试验的系统评价和荟萃分析
Cureus. 2023 Nov 11;15(11):e48674. doi: 10.7759/cureus.48674. eCollection 2023 Nov.
7
An Early View of Real-World Patient Response to Sacubitril/Valsartan: A Retrospective Study of Patients with Heart Failure with Reduced Ejection Fraction.真实世界中沙库巴曲缬沙坦治疗患者反应的早期观察：射血分数降低的心力衰竭患者的回顾性研究。
Adv Ther. 2018 Jun;35(6):785-795. doi: 10.1007/s12325-018-0710-4. Epub 2018 May 17.
8
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.沙库巴曲缬沙坦治疗射血分数轻度降低或保留的心力衰竭：PARAGLIDE-HF 和 PARAGON-HF 的预先指定的参与者水平汇总分析。
Eur Heart J. 2023 Aug 14;44(31):2982-2993. doi: 10.1093/eurheartj/ehad344.
9
Real-world treatment switching to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: A cohort study.射血分数降低的心力衰竭患者实际应用中转换为沙库巴曲缬沙坦治疗：一项队列研究。
Open Heart. 2020 Oct;7(2). doi: 10.1136/openhrt-2020-001305.
10
Canadian Real-World Experience of Using Sacubitril/Valsartan in Patients With Heart Failure With Reduced Ejection Fraction: Insight From the PARASAIL Study.沙库巴曲缬沙坦在射血分数降低的心力衰竭患者中应用的加拿大真实世界经验：来自PARASAIL研究的见解
CJC Open. 2020 Apr 26;2(5):344-353. doi: 10.1016/j.cjco.2020.04.007. eCollection 2020 Sep.

本文引用的文献

1
Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical setting.沙库巴曲缬沙坦在真实临床环境中用于射血分数降低的心力衰竭的早期经验。
ESC Heart Fail. 2020 Jun;7(3):1049-1055. doi: 10.1002/ehf2.12644. Epub 2020 Feb 6.

Correction to 'Early experience of Sacubitril-Valsartan in heart failure with reduced ejection fraction in real-world clinical setting'.

出版信息

ESC Heart Fail. 2025 Apr;12(2):1525. doi: 10.1002/ehf2.15211. Epub 2025 Jan 17.

DOI:10.1002/ehf2.15211
PMID:39821647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11911563/
Abstract
摘要